吉利德:收购一家biotech HIV药物管线,HIV药物大卖181.75亿美元!

生物药大时代
29 Nov 2024

声明:因水平有限,错误不可避免,或有些信息非最及时,欢迎留言指出。本文仅作医疗健康相关药物介绍,非治疗方案推荐(若涉及);本文不构成任何投资建议。吉利德长期以来以其HIV药物而闻名,它通过从西班牙一家鲜为人知的生物技术公司获得针对顽固病毒的研究疫苗,进一步深入研究该领域。吉利德正在支付未披露的金额,从总部位于巴塞罗那的Aelix Therapeutics购买 HTI T 细胞免疫原 HIV 疫苗,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10